BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35262907)

  • 1. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
    Klein B; Treudler R; Dumann K; Boldt A; Schumann I; Simon JC; Kunz M
    Br J Dermatol; 2022 Sep; 187(3):419-422. PubMed ID: 35262907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic findings characteristic of CARD14-associated papulosquamous eruption.
    Ring NG; Craiglow BG; Panse G; Antaya RJ; Ashack K; Ashack R; Faith EF; Paller AS; McNiff JM; Choate KA; Ko CJ
    J Cutan Pathol; 2020 May; 47(5):425-430. PubMed ID: 31849081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in a CARD14-associated papulosquamous eruption.
    Li N; Tao J; Zhang J; Liu Z; Yu P
    Pediatr Dermatol; 2023; 40(4):706-709. PubMed ID: 36724903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
    Craiglow BG; Boyden LM; Hu R; Virtanen M; Su J; Rodriguez G; McCarthy C; Luna P; Larralde M; Humphrey S; Holland KE; Hogeling M; Hidalgo-Matlock B; Ferrari B; Fernandez-Faith E; Drolet B; Cordoro KM; Bowcock AM; Antaya RJ; Ashack K; Ashack RJ; Lifton RP; Milstone LM; Paller AS; Choate KA
    J Am Acad Dermatol; 2018 Sep; 79(3):487-494. PubMed ID: 29477734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.
    Frare CP; Blumstein AJ; Paller AS; Pieretti L; Choate KA; Bowcock AM; Larralde M
    Pediatr Dermatol; 2021 Sep; 38(5):1237-1242. PubMed ID: 34448248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child.
    Kiszewski AE; De Almeida HL
    Dermatol Ther; 2022 Dec; 35(12):e15939. PubMed ID: 36239488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
    Eytan O; Sarig O; Sprecher E; van Steensel MA
    Br J Dermatol; 2014 Aug; 171(2):420-2. PubMed ID: 24641799
    [No Abstract]   [Full Text] [Related]  

  • 8. CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
    Inoue N; Dainichi T; Fujisawa A; Nakano H; Sawamura D; Kabashima K
    J Dermatol; 2016 Feb; 43(2):187-9. PubMed ID: 26130407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial pityriasis rubra pilaris is caused by mutations in CARD14.
    Fuchs-Telem D; Sarig O; van Steensel MA; Isakov O; Israeli S; Nousbeck J; Richard K; Winnepenninckx V; Vernooij M; Shomron N; Uitto J; Fleckman P; Richard G; Sprecher E
    Am J Hum Genet; 2012 Jul; 91(1):163-70. PubMed ID: 22703878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
    Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
    Volc-Platzer B
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1312-1315. PubMed ID: 32881385
    [No Abstract]   [Full Text] [Related]  

  • 13. The beneficial effect of a PDE4 inhibitor in a patient with juvenile-onset intractable pityriasis rubra pilaris without CARD14 mutation.
    Inoue E; Arase N; Hanaoka Y; Tanemura A; Fujimoto M
    Dermatol Ther; 2021 Jan; 34(1):e14714. PubMed ID: 33368948
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial pityriasis rubra pilaris in a Chinese family caused by a novel mutation in CARD14 gene.
    Wu T; Banerjee S; Deng J; Wu J; Huang H; Zheng H; Pan H; Wang Y; Peng Z; Sun X
    Indian J Dermatol Venereol Leprol; 2020; 86(1):81-84. PubMed ID: 31755479
    [No Abstract]   [Full Text] [Related]  

  • 15. CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.
    Wong GHZ; Chia SY; Wei H; Rafi'ee K; Koh MJA; Tan EC
    Pediatr Dermatol; 2021 Jul; 38(4):970-972. PubMed ID: 34075616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
    Takeichi T; Sugiura K; Nomura T; Sakamoto T; Ogawa Y; Oiso N; Futei Y; Fujisaki A; Koizumi A; Aoyama Y; Nakajima K; Hatano Y; Hayashi K; Ishida-Yamamoto A; Fujiwara S; Sano S; Iwatsuki K; Kawada A; Suga Y; Shimizu H; McGrath JA; Akiyama M
    JAMA Dermatol; 2017 Jan; 153(1):66-70. PubMed ID: 27760266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
    Eytan O; Qiaoli L; Nousbeck J; van Steensel MA; Burger B; Hohl D; Taïeb A; Prey S; Bachmann D; Avitan-Hersh E; Jin Chung H; Shemer A; Trau H; Bergman R; Fuchs-Telem D; Warshauer E; Israeli S; Itin PH; Sarig O; Uitto J; Sprecher E
    Br J Dermatol; 2014 May; 170(5):1196-8. PubMed ID: 24359224
    [No Abstract]   [Full Text] [Related]  

  • 18. A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.
    Nogueira M; Reis J; Abreu M; Coelho A; Reis CF; Machado S
    Pediatr Dermatol; 2023; 40(6):1104-1106. PubMed ID: 37219506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.
    Lwin SM; Hsu CK; Liu L; Huang HY; Levell NJ; McGrath JA
    Br J Dermatol; 2018 Apr; 178(4):969-972. PubMed ID: 28301045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a pathogenic
    Nielsen RM; Gram SB; Bygum A
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.